Everolimus, an immunosuppressive drug, is prescribed for the management of graft rejection in graft versus host disease (GVHD) in organ transplanted patients. Everolimus is commonly prescribed in kidney and/or liver transplanted, renal cancer patients. Everolimus is prescribed as a combined therapy with cyclosporine, corticosteroids and other medications.
